Cuorips (TSE:4894) Other Stockholders Equity: 円89.3 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4894 Cuorips Inc TSE:4894
66 GF Score
Price 円4,885.00
GF Value 円28,988.13
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Cuorips Other Stockholders Equity?

Cuorips TSE:4894 +16.73% 66 Other Stockholders Equity is 円89.3 Mil as of Mar. 2026. GuruFocus rates TSE:4894 with a GF Score™ of 66/100 and a GF Value™ of 円28,988.13 (Possible Value Trap). The stock has 2 warning signs investors should review.

Cuorips's Other Stockholders Equity for the quarter that ended in Mar. 2026 was 円89.3 Mil.

Cuorips's quarterly Other Stockholders Equity increased from Mar. 2025 (円52.8 Mil) to Sep. 2025 (円86.9 Mil) and increased from Sep. 2025 (円86.9 Mil) to Mar. 2026 (円89.3 Mil).

Cuorips's annual Other Stockholders Equity increased from Mar. 2024 (円7.8 Mil) to Mar. 2025 (円52.8 Mil) and increased from Mar. 2025 (円52.8 Mil) to Mar. 2026 (円89.3 Mil).

Cuorips Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cuorips's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cuorips Other Stockholders Equity Chart

Cuorips Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial 15.79 16.58 7.77 52.77 89.26

Cuorips Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only 7.77 11.09 52.77 86.89 89.26
TSE:4894
66GF Score
Cuorips Inc TSE:4894
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cuorips Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of 円89.3 Mil mean?
Cuorips (TSE:4894) has a Other Stockholders Equity of 円89.3 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cuorips and its competitors.
Is Cuorips' Other Stockholders Equity too high?
Cuorips' current Other Stockholders Equity is 円89.3 Mil. Overall, Cuorips has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cuorips' Other Stockholders Equity compare to VRTX and REGN?
Cuorips' Other Stockholders Equity of 円89.3 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cuorips and its competitors. Cuorips's current Other Stockholders Equity is 円89.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cuorips stock overvalued right now?
Based on GuruFocus' analysis, Cuorips (TSE:4894) is currently considered Possible Value Trap. The stock's GF Value™ is 円28,988.13, compared to a current price of 円4,885.00 — trading 83.1% below its estimated fair value. The current Other Stockholders Equity is 円89.3 Mil. Cuorips' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Cuorips (TSE:4894), the current Other Stockholders Equity is 円89.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cuorips (TSE:4894) Overvalued in 2026?

Based on GuruFocus' analysis, Cuorips stock appears to be undervalued. The current stock price of 円4,885.00 is trading 83.1% below its estimated GF Value™ of 円28,988.13. GuruFocus considers Cuorips to be Possible Value Trap.

Key valuation signals for TSE:4894:

  • Other Stockholders Equity: 円89.3 Mil
  • GF Value™: 円28,988.13 vs. price of 円4,885.00 (83.1% below fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the TSE:4894 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cuorips Business Description

Address 3-11-5 Nihonbashi-Honcho, 507, Nihonbashi Life Science Building 2, Chuo-ku, Tokyo, JPN, 103-0023
Cuorips Inc is engaged in the Research, development, manufacturing, and sales of Cellular and Tissue-based Products and Cell processing products. The company is also engaged in Contract development and manufacturing services and consulting services of Cellular and Tissue-based Products and Cell processing product.
66GF Score

Get the complete analysis for TSE:4894

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,885.00
Price
円28,988.13
GF Value